A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
Clinical trial NCT01667419 · COMPLETED
Trial details
- NCT number
- NCT01667419
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-24
- Primary completion
- 2017-06-23
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.